forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Outlook for obesity in 2025: more than a transition year GLP-1 Weight Loss Drug Market

A September 2025 study found creatine paired with resistance training increased fat-free mass by about 1.39 kg on average, which is a useful benchmark for what real lean-mass movement can look like over time

National Association of Insurance Commissioners

If the BUD is 30 days away but you opened the vial 25 days ago, you effectively have about 3 days left (28-day post-opening limit)

Shima Hadidchi MD Family Practice, we are committed to offering our patients the latest, evidence-based options for managing chronic conditions such as type 2 diabetes and obesity

Precision health benefits Anecdotal evidence suggests that microdosing could unlock longevity benefits like improved moods, reduced inflammation, better immunity, and reduced symptoms of chronic and autoimmune conditions

May your injection timing stay consistent, your side effects stay manageable, and your results stay on track.